YOLANDA JUSTAL: Open Payments
NPI 1871193755 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 12 payments from 7 companies in 2025. Trend: 2023 $135 · 2024 $2,493 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $244 |
| Janssen Biotech, Inc. | 3 | $151 |
| Exelixis Inc. | 1 | $115 |
| Astellas Pharma US Inc | 2 | $52 |
| Caris MPI, Inc. | 2 | $46 |
| PFIZER INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: RYBREVANT, CABOMETYX, Xtandi, MI CANCER SEEK, ERLEADA, PLUVICTO.
Industry payments across FL — which companies pay providers there.
